Antonella Zucchetto

18PUBLICATIONS
112CO-AUTHORS
Tumour immunologyOther biological sciences not elsewhere classifiedHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

|Apr 02, 2026
No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

Luca Laurenti, Feliciana Guglielmi, Antonio Mosca

|Mar 06, 2026
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Laura Polcik, Abhishek Pethe, Driti Ashok

|Jun 10, 2025
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens.

Claudia Matteucci, Vita Petrone, Alessandro Giovinazzo

|Jan 18, 2025
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Riccardo Moia, Donatella Talotta, Lodovico Terzi Di Bergamo

|Jun 26, 2024
Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.

Simone Mirabilii, Monica Piedimonte, Esmeralda Conte

Pageof 3

Frequent Collaborators

4 joint publications

Luca Laurenti

4 joint publications

Massimo Gentile

3 joint publications

Valter Gattei

3 joint publications

Riccardo Bomben